Release Date: 08/07/13 08:26 Summary: The Ulaan Tolgoi Project Joint Venture Formalised Price Sensitive: Yes Download Document 418.39KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%